BD

Bimla Devi Bhartia

Active Director Director DIN 00705415
DIN 00705415 First appointment Dec 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Bimla Devi Bhartia

Data last updated:

Bimla Devi Bhartia is a Director at G.T.Pharma Private Limited (since 2006). The company operates in Pharma.

DIN 00705415
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2006
Oldest Company Age 31 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
G.T.Pharma Private Limited U24232RJ1995PTC010190
Director27 Dec 20061995Active

Board colleagues of Bimla Devi Bhartia

NameDINCompanyDesignation
Madhu Bhartia01276079G.T.Pharma Private LimitedDirector
Sanjay Kumar Bhartia00275439G.T.Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
G.T.Pharma Private Limited
Premium access

Shareholding and investment profile for Bimla Devi Bhartia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bimla Devi Bhartia

Bimla Devi Bhartia currently holds 1 directorship: G.T.Pharma Private Limited (Director, since 27 Dec 2006).

Bimla Devi Bhartia was first appointed on 27 Dec 2006 as Director at G.T.Pharma Private Limited.

The current boards of Bimla Devi Bhartia's companies include Madhu Bhartia (G.T.Pharma Private Limited), Sanjay Kumar Bhartia (G.T.Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available